Abbott Laboratories (ABT)vsButterfly Network Inc (BFLY)
ABT
Abbott Laboratories
$91.07
+0.56%
HEALTHCARE · Cap: $151.49B
BFLY
Butterfly Network Inc
$4.57
-11.95%
HEALTHCARE · Cap: $1.20B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 43756% more annual revenue ($45.13B vs $102.92M). ABT leads profitability with a 13.9% profit margin vs -73.6%. ABT earns a higher WallStSmart Score of 56/100 (C).
ABT
Buy56
out of 100
Grade: C
BFLY
Avoid25
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-28.5%
Fair Value
$70.89
Current Price
$91.07
$20.18 premium
Intrinsic value data unavailable for BFLY.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Conservative balance sheet, low leverage
Revenue surging 25.0% year-over-year
Areas to Watch
Earnings declined 19.7%
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -39.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap. PEG of 1.30 suggests the stock is reasonably priced for its growth.
Bull Case : BFLY
The strongest argument for BFLY centers on Debt/Equity, Revenue Growth. Revenue growth of 25.0% demonstrates continued momentum.
Bear Case : ABT
The primary concerns for ABT are EPS Growth.
Bear Case : BFLY
The primary concerns for BFLY are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
ABT profiles as a value stock while BFLY is a growth play — different risk/reward profiles.
BFLY carries more volatility with a beta of 2.28 — expect wider price swings.
BFLY is growing revenue faster at 25.0% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Bottom Line
ABT scores higher overall (56/100 vs 25/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Butterfly Network Inc
HEALTHCARE · MEDICAL DEVICES · USA
Butterfly Network, Inc., a digital health company, develops, manufactures, and markets ultrasound imaging solutions in the United States and internationally. The company is headquartered in Guilford, Connecticut.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?